<qa>  What is the name of the PHASE III TRIAL of STEREPHASE III TRIAL OF STEREOTACTIC BODY RADIOTHERAPY WITH CONCURRENT FIXED DOSE TYROSINE KINASE INHIBITORS IN METASTATIC RENAL CELL CARCINOMA: DOSE LIMITING TOXICITY AND ABSCOPAL EFFECT.: 